Nissan Medical Industries Ltd (NISA.TA)
ILA 1160.0
(0.0%)
ILA 1160.0
(0.0%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 135.77 Million ILS | 63.04% |
| 2022 | 83.27 Million ILS | -42.34% |
| 2021 | 144.41 Million ILS | -20.41% |
| 2020 | 181.44 Million ILS | 89.87% |
| 2019 | 95.56 Million ILS | -20.07% |
| 2018 | 119.55 Million ILS | 33.65% |
| 2017 | 89.44 Million ILS | -16.44% |
| 2016 | 107.04 Million ILS | -30.52% |
| 2015 | 154.07 Million ILS | 26.28% |
| 2014 | 122.01 Million ILS | 12.44% |
| 2013 | 108.51 Million ILS | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 40.17 Million ILS | -9.57% |
| 2024 Q2 | 26.88 Million ILS | -33.08% |
| 2023 Q2 | 33.3 Million ILS | 42.21% |
| 2023 Q1 | 23.42 Million ILS | 32.25% |
| 2023 Q3 | 34.63 Million ILS | 3.98% |
| 2023 FY | 135.77 Million ILS | 63.04% |
| 2023 Q4 | 44.42 Million ILS | 28.27% |
| 2022 FY | 83.27 Million ILS | -42.34% |
| 2022 Q4 | 17.71 Million ILS | 24.29% |
| 2022 Q3 | 14.24 Million ILS | -45.29% |
| 2022 Q1 | 25.27 Million ILS | 7.32% |
| 2022 Q2 | 26.04 Million ILS | 3.05% |
| 2021 Q1 | 53.75 Million ILS | 2.02% |
| 2021 Q4 | 23.54 Million ILS | 52.32% |
| 2021 FY | 144.41 Million ILS | -20.41% |
| 2021 Q2 | 51.65 Million ILS | -3.92% |
| 2021 Q3 | 15.46 Million ILS | -70.07% |
| 2020 Q1 | 33.97 Million ILS | 33.67% |
| 2020 Q2 | 43.82 Million ILS | 28.99% |
| 2020 Q4 | 52.69 Million ILS | 3.39% |
| 2020 Q3 | 50.96 Million ILS | 16.3% |
| 2020 FY | 181.44 Million ILS | 89.87% |
| 2019 Q2 | 19.78 Million ILS | -31.61% |
| 2019 Q1 | 28.93 Million ILS | -15.86% |
| 2019 FY | 95.56 Million ILS | -20.07% |
| 2019 Q4 | 25.41 Million ILS | 18.59% |
| 2019 Q3 | 21.43 Million ILS | 8.32% |
| 2018 Q3 | 26.1 Million ILS | -18.72% |
| 2018 Q4 | 34.38 Million ILS | 31.72% |
| 2018 Q2 | 32.11 Million ILS | 19.17% |
| 2018 FY | 119.55 Million ILS | 33.65% |
| 2018 Q1 | 26.95 Million ILS | 22.21% |
| 2017 FY | 89.44 Million ILS | -16.44% |
| 2017 Q1 | 20.04 Million ILS | -9.89% |
| 2017 Q2 | 21.84 Million ILS | 8.99% |
| 2017 Q3 | 25.5 Million ILS | 16.77% |
| 2017 Q4 | 22.05 Million ILS | -13.55% |
| 2016 Q3 | 23.64 Million ILS | -17.16% |
| 2016 FY | 107.04 Million ILS | -30.52% |
| 2016 Q4 | 22.24 Million ILS | -5.93% |
| 2016 Q2 | 28.54 Million ILS | -12.44% |
| 2016 Q1 | 32.6 Million ILS | -20.98% |
| 2015 Q2 | 37.57 Million ILS | 1.4% |
| 2015 Q3 | 38.19 Million ILS | 1.65% |
| 2015 FY | 154.07 Million ILS | 26.28% |
| 2015 Q1 | 37.05 Million ILS | 5.57% |
| 2015 Q4 | 41.26 Million ILS | 8.04% |
| 2014 Q1 | 28.57 Million ILS | -2.23% |
| 2014 Q2 | 25.05 Million ILS | -12.33% |
| 2014 Q3 | 33.28 Million ILS | 32.88% |
| 2014 FY | 122.01 Million ILS | 12.44% |
| 2014 Q4 | 35.09 Million ILS | 5.44% |
| 2013 FY | 108.51 Million ILS | 0.0% |
| 2013 Q1 | 24.72 Million ILS | 0.0% |
| 2013 Q2 | 27.11 Million ILS | 9.69% |
| 2013 Q3 | 27.44 Million ILS | 1.21% |
| 2013 Q4 | 29.22 Million ILS | 6.48% |
| Name | Gross Profit | Gross Profit Difference |
|---|